Novo Nordisk A/S (NVO)

52.56 +0.95 (+1.84%) USD  |  NYSE  |  Dec 24, 16:00
53.10 +0.54 (+1.03%) Pre-Market: 08:30
More

Novo Nordisk Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS --
Regeneron Pharmaceuticals, Inc. Upgrade
Omeros Corp. Upgrade
Viking Therapeutics, Inc. Upgrade